Table 6.
Patient tolerance to bowel preparation according to 5‐point visual analog scale
| Type of preparation | P‐value | ||
|---|---|---|---|
| WD/PICO (n = 125) | CF/PEG + SPMC (n = 125) | ||
| Bloating, median (IQR) | 1 (1–1) (n = 88) |
1 (1–2) (n = 100) |
0.02 |
| Abdominal cramping, median (IQR) | 1 (1–2) (n = 89) |
1 (1–2) (n = 101) |
0.28 |
| Nausea, median (IQR) | 1 (1–2) (n = 92) |
1 (1–3) (n = 101) |
0.22 |
| Headache, median (IQR) | 1 (1–2) (n = 95) |
2 (1–3) (n = 101) |
0.13 |
| Weakness, median (range) | 1 (1–4) (n = 91) |
1 (1–5) (n = 101) |
0.046 |
| Sleeping difficulty, median (IQR) | 1 (1–3) (n = 94) |
1 (1–3) (n = 101) |
0.42 |
| Hunger, median (IQR) | 1 (1–2) (n = 92) |
3 (2–4) (n = 104) |
<0.0001 |
| Interference with daily activities, median (IQR) | 2 (1–2) (n = 92) |
2 (1–3) (n = 104) |
0.001 |
| Vomiting post‐bowel preparation, n (%) | 5 (4.7) (n = 107) |
7 (6.4) (n = 110) |
0.59 |
CF, clear fluid; IQR, interquartile range; PEG, polyethylene glycol; PICO, picosalax; SPMC, sodium picosulfate/magnesium citrate; WD, White Diet.